Trademark Overview
On Wednesday, April 24, 2024, a trademark application was filed for VIANAUTIS with the United States Patent and Trademark Office. The USPTO has given the VIANAUTIS trademark a serial number of 98516669. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 24, 2024. This trademark is owned by VIANAUTIS BIO LIMITED. The VIANAUTIS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; reagents, diagnostics, prophylactics and therapeutic preparations for use in conditions of the central and peripheral nervous systems, diseases of the lung, kidney, liver or any peripheral organs, and oncology; vaccines; therapeutic preparations for use in treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, and cancer in medical and veterinary patients; targeted preparations for treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, or cancer; medical and veterinary preparations for use in central and peripheral nervous system diseases, diseases of the lung, kidney, liver and other organs, and cancer; medical and veterinary preparations for the delivery of compounds to the brain; medical and veterinary preparations for crossing the blood-brain barrier and other biological barriers; medical and veterinary preparations for delivering reagen...
Chemicals used in science; chemicals for encapsulating, microencapsulating and decapsulating other chemicals; chemicals for the protection, delivery, transport and triggered or controlled release of other chemicals; chemicals for encapsulating, microencapsulating and decapsulating biologically active ingredients including enzymes and cells.
Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services; scientific research in the development of new therapies and new methods for delivering therapies; scientific research into nanoparticles; scientific research into encapsulation, microencapsulation and de-capsulation of reagents, diagnostics, prophylactics and therapeutics; scientific research into crossing the blood brain barrier and other biological barriers; scientific research into nano-engineering for intracellular delivery; consultancy relating to all the aforesaid services.
